CRISPR-Cas9 editing of TNFAIP3 variants in salivary gland epithelial cells to study Sjögren's disease pathogenesis
- PMID: 40771660
- PMCID: PMC12326134
- DOI: 10.3389/fgeed.2025.1625393
CRISPR-Cas9 editing of TNFAIP3 variants in salivary gland epithelial cells to study Sjögren's disease pathogenesis
Abstract
Sjögren's disease (SD) is a systemic autoimmune disease that particularly affects the salivary and lacrimal glands, causing sicca symptoms. Genetic polymorphism in the TNFAIP3 gene has been implicated in the pathogenesis of SD. In this study, we aimed to functionally determine the impact of two specific single-nucleotide polymorphisms (SNPs) in TNFAIP3, rs6920220 (G/A) and rs2230926 (T/C/G), on the pathogenesis of SD. Using CRISPR-Cas9, we edited human salivary gland epithelial cells (SGECs) to incorporate TNFAIP3 SNPs rs6920220 (G/A) and rs2230926 (T/C/G) and co-cultured them with Jurkat cells. We performed assays to examine gene expression, inflammatory cytokine levels, and related signaling pathways to investigate the effects of these genetic variants on TNFAIP3 function and cellular response. Our results demonstrated that these SNPs reduced TNFAIP3 expression, increased NF-κB activation, and elevated pro-inflammatory cytokine production. These findings provide strong evidence for the functional significance of these genetic variants in the pathogenesis of SD and underscore the utility of CRISPR-Cas9 technology in elucidating genetic contributions to autoimmune disorders.
Keywords: CRISPR-Cas9; NF-κB; Sjögren’s disease; TNFAIP3; autoimmune diseases; salivary gland; single-nucleotide polymorphisms.
Copyright © 2025 Ghosh, Tu, Zhu, Panginikkod and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Clinical, histopathological, and immunohistochemical characteristics of patients with sicca syndrome with a focus score ≥ 1 in the minor salivary gland biopsy.Biomedica. 2025 Mar 28;45(1):80-93. doi: 10.7705/biomedica.7315. Biomedica. 2025. PMID: 40257948 Free PMC article. English, Spanish.
-
SHP2 Allosteric Inhibitor SHP099 Alleviates Inflammation and Restores Salivary Gland Function in Sjögren's Disease-like Animals via Regulation of the IL-17RA Signaling Pathway.Int Immunopharmacol. 2025 Aug 28;161:114986. doi: 10.1016/j.intimp.2025.114986. Epub 2025 Jun 3. Int Immunopharmacol. 2025. PMID: 40466613
-
miR-216a-3p alleviates primary Sjögren's syndrome by regulating the STAT1/JAK signaling pathway.Biochem Biophys Res Commun. 2025 Apr 12;758:151647. doi: 10.1016/j.bbrc.2025.151647. Epub 2025 Mar 17. Biochem Biophys Res Commun. 2025. PMID: 40121969
-
Interventions for the management of dry mouth: non-pharmacological interventions.Cochrane Database Syst Rev. 2013 Sep 5;2013(9):CD009603. doi: 10.1002/14651858.CD009603.pub3. Cochrane Database Syst Rev. 2013. PMID: 24006231 Free PMC article.
-
Transferable approaches to CRISPR-Cas9 induced genome editing in non-model insects: a brief guide.Front Zool. 2025 Jul 7;22(1):13. doi: 10.1186/s12983-025-00566-2. Front Zool. 2025. PMID: 40624545 Free PMC article. Review.
References
-
- Carsons S. E., Patel B. C. (2023). Sjogren syndrome. Treasure Island (FL): StatPearls Publishing. - PubMed
-
- Ciccacci C., Latini A., Perricone C., Conigliaro P., Colafrancesco S., Ceccarelli F., et al. (2019). TNFAIP3 gene polymorphisms in three common autoimmune diseases: systemic Lupus Erythematosus, rheumatoid arthritis, and primary sjogren syndrome—association with disease susceptibility and clinical phenotypes in Italian patients. J. Immunol. Res. 2019, 6728694–6728696. 10.1155/2019/6728694 - DOI - PMC - PubMed
-
- Fujimura T., Fujimoto T., Itaya-Hironaka A., Miyaoka T., Yoshimoto K., Sakuramoto-Tsuchida S., et al. (2017). Significance of interleukin-6/STAT pathway for the gene expression of REG iα, a new autoantigen in sjögren's syndrome patients, in salivary duct epithelial cells. Clin. Rev. Allergy and Immunol. 52, 351–363. 10.1007/s12016-016-8570-7 - DOI - PubMed
LinkOut - more resources
Full Text Sources